Brief: Anixa Biosciences Announces Issuance Of Canadian Patent For Its Car-T Cancer Therapy Technology
11/07/2023 14:10
July 11 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES ANNOUNCES ISSUANCE OF CANADIAN PATENT
FOR ITS
CAR-T CANCER THERAPY TECHNOLOGY
* ANIXA BIOSCIENCES INC - TECHNOLOGY CURRENTLY BEING
EVALUATED FOR
TREATMENT OF OVARIAN CANCER IN PHASE 1 CLINICAL TRIAL
Source text for Eikon: ID:nPn20H5PJa
Further company coverage: ANIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine